XML 30 R20.htm IDEA: XBRL DOCUMENT
v3.19.1

Net Loss per Share (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2019
Earnings Per Share [Abstract] |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | The following tables set forth the computation of diluted net loss per weighted average number of shares outstanding attributable to Synthetic Biologics, Inc. and Subsidiaries for the three months ended March 31, 2019 and 2018 (in thousands except share and per share amounts) :
|  | Three months ended March 31, 2019 |  |  | Three months ended March 31, 2018 |
|  | Net loss (Numerator) |  |  | Shares (Denominator) |  |  | Per Share Amount |  |  | Net Loss (Numerator) |  |  | Shares (Denominator) |  |  | Per Share Amount |
Net loss - Basic |  | $ | (3,971 | ) |  |  | 15,656,784 |  |  | $ | (0.25 | ) |  | $ | (2,375 | ) |  |  | 3,673,340 |  |  | $ | (0.65 | )
Dilutive shares related to warrants |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Net loss - Dilutive |  | $ | (3,971 | ) |  |  | 15,656,784 |  |  | $ | (0.25 | ) |  | $ | (2,375 | ) |  |  | 3,673,340 |  |  | $ | (0.65 | )

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration